Rheumatic - Joint Care
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:00
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Rheumatic - Joint Care Formulated for symptoms associated with uric acid build-up such as joint pain, inflammation and discomfort.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) one to four times daily or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose.
OTC - ACTIVE INGREDIENT SECTION
Uricum acidum 15x, Aconitum nap. 10x, Apis mel. 10x, Arnica 10x, Arsenicum alb. 10x, Belladonna 10x, Benzoicum acidum 10x, Bryonia 10x, Calc. carb. 10x, Chamomilla 10x, Cinchona 10x, Colchicum 10x, Eupatorium perf. 10x, Gaultheria procumbens 10x, Guaiacum 10x, Iodium 10x, Kali bic. 10x, Kalmia 10x, Ledum 10x, Pulsatilla 10x, Rhus toxicodendron 10x, Ruta 10x, Sabina 10x, Strychninum 10x, Lappa 3x, Phytolacca 3x, Symphytum 3x.
OTC - PURPOSE SECTION
Formulated for symptoms associated with uric acid build-up such as joint pain, inflammation and discomfort.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children
OTC - PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
| 5f30b278-5791-4113-8781-878a9221ef8a | Product name | 2 | 20230125 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 2a70c781-a755-4d76-b20a-a958acfbdcdc | Product name | 2 | 20190619 |
| 304592ef-4a8a-4c22-8e8c-af73aa3d60e5 | Product name | 1 | 20180703 |
| ac0821a1-ce75-4ea7-880a-59eecaecdf22 | Product name | 1 | 20180703 |
| db5dc4f9-b907-46f6-8fb7-babcf04bbe5c | Product name | 1 | 20180619 |
| 41e9d6cf-3ed7-4c44-a57e-0685058d0896 | Product name | 1 | 20170824 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 5e652c92-68fd-426b-b0e7-5fc64e0b9f99 | Product name | 1 | 20170309 |
| ddc0c11a-bba8-408f-b3c7-c4828b4bcc8c | Product name | 1 | 20150421 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-2217-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0040-f424-e053-dadaa90a57ce | Rheumatic - Joint Care |
| 55714-2217-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0040-f424-e053-dadaa90a57ce | Rheumatic - Joint Care |
| 55714-2217-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0040-f424-e053-dadaa90a57ce | Rheumatic - Joint Care |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-2217-0 | Rheumatic - Joint Care | 7.08 g in 1 BOTTLE, GLASS | PELLET | 7.08 | 2 | |
| 55714-2217-1 | Rheumatic - Joint Care | 28.35 g in 1 BOTTLE, GLASS | PELLET | 28.35 | 2 | |
| 55714-2217-2 | Rheumatic - Joint Care | 56.7 g in 1 BOTTLE, GLASS | PELLET | 56.7 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-2217 | RHEUMATIC - JOINT CARE (URICUM ACIDUM, ACONITUM NAP.,APIS MEL., ARNICA, ARSENICUM ALB, BELLADONNA,BENZOICUM ACIDUM, BRYONIA, CALC. CARB., CHAMOMILLA, CINCHONA, COLCHICUM, EUPATORIUM PERF., GAULTHERIAPROCUMBENS, GUAIACUM, IODIUM, KALI BIC, KALMIA,LEDUM, PULSATILLA, RHUS TOXICODENDRON, RUTA,SABINA, STRYCHNINUM, LAPPA, PHYTOLACCA, SYMPHYTUM,) PELLET [NEWTON LABORATORIES, INC.] | 2 | Legacy NDC, 3 package rows | 20131011_cc3eac44-a75d-9768-b9c0-d81dca9ecefa.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 2 | |
| Apis Mellifera | ACTIVE INGREDIENT | 7S82P3R43Z | 2 | |
| Arctium Lappa Root | ACTIVE INGREDIENT | 597E9BI3Z3 | 2 | |
| Arnica Montana | ACTIVE INGREDIENT | O80TY208ZW | 2 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 2 | |
| Atropa Belladonna | ACTIVE INGREDIENT | WQZ3G9PF0H | 2 | |
| Benzoic Acid | ACTIVE INGREDIENT | 8SKN0B0MIM | 2 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 2 | |
| Cinchona Officinalis Bark | ACTIVE INGREDIENT | S003A158SB | 2 | |
| Colchicum Autumnale Bulb | ACTIVE INGREDIENT | 993QHL78E6 | 2 | |
| Comfrey Root | ACTIVE INGREDIENT | M9VVZ08EKQ | 2 | |
| Eupatorium Perfoliatum Flowering Top | ACTIVE INGREDIENT | 1W0775VX6E | 2 | |
| Gaultheria Procumbens Top | ACTIVE INGREDIENT | 830295X963 | 2 | |
| Guaiacum Officinale Resin | ACTIVE INGREDIENT | N0K2Z502R6 | 2 | |
| Iodine | ACTIVE INGREDIENT | 9679TC07X4 | 2 | |
| Juniperus Sabina Leafy Twig | ACTIVE INGREDIENT | Z5BEX9K2G1 | 2 | |
| Kalmia Latifolia Leaf | ACTIVE INGREDIENT | 79N6542N18 | 2 | |
| Ledum Palustre Twig | ACTIVE INGREDIENT | 877L01IZ0P | 2 | |
| Matricaria Recutita | ACTIVE INGREDIENT | G0R4UBI2ZZ | 2 | |
| Oyster Shell Calcium Carbonate, Crude | ACTIVE INGREDIENT | 2E32821G6I | 2 | |
| Phytolacca Americana Root | ACTIVE INGREDIENT | 11E6VI8VEG | 2 | |
| Potassium Dichromate | ACTIVE INGREDIENT | T4423S18FM | 2 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 2 | |
| Ruta Graveolens Flowering Top | ACTIVE INGREDIENT | N94C2U587S | 2 | |
| Strychnine | ACTIVE INGREDIENT | H9Y79VD43J | 2 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 2 | |
| Uric Acid | ACTIVE INGREDIENT | 268B43MJ25 | 2 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 2 | |
| Apis Mellifera | ACTIVE MOIETY | 7S82P3R43Z | 2 | |
| Arctium Lappa Root | ACTIVE MOIETY | 597E9BI3Z3 | 2 | |
| Arnica Montana | ACTIVE MOIETY | O80TY208ZW | 2 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 2 | |
| Atropa Belladonna | ACTIVE MOIETY | WQZ3G9PF0H | 2 | |
| Benzoic Acid | ACTIVE MOIETY | 8SKN0B0MIM | 2 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 2 | |
| Cinchona Officinalis Bark | ACTIVE MOIETY | S003A158SB | 2 | |
| Colchicum Autumnale Bulb | ACTIVE MOIETY | 993QHL78E6 | 2 | |
| Comfrey Root | ACTIVE MOIETY | M9VVZ08EKQ | 2 | |
| Dichromate Ion | ACTIVE MOIETY | 9LKY4BFN2V | 2 | |
| Eupatorium Perfoliatum Flowering Top | ACTIVE MOIETY | 1W0775VX6E | 2 | |
| Gaultheria Procumbens Top | ACTIVE MOIETY | 830295X963 | 2 | |
| Guaiacum Officinale Resin | ACTIVE MOIETY | N0K2Z502R6 | 2 | |
| Iodine | ACTIVE MOIETY | 9679TC07X4 | 2 | |
| Juniperus Sabina Leafy Twig | ACTIVE MOIETY | Z5BEX9K2G1 | 2 | |
| Kalmia Latifolia Leaf | ACTIVE MOIETY | 79N6542N18 | 2 | |
| Ledum Palustre Twig | ACTIVE MOIETY | 877L01IZ0P | 2 | |
| Matricaria Recutita | ACTIVE MOIETY | G0R4UBI2ZZ | 2 | |
| Oyster Shell Calcium Carbonate, Crude | ACTIVE MOIETY | 2E32821G6I | 2 | |
| Phytolacca Americana Root | ACTIVE MOIETY | 11E6VI8VEG | 2 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 2 | |
| Ruta Graveolens Flowering Top | ACTIVE MOIETY | N94C2U587S | 2 | |
| Strychnine | ACTIVE MOIETY | H9Y79VD43J | 2 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 2 | |
| Uric Acid | ACTIVE MOIETY | 268B43MJ25 | 2 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 2 |
Products#
Every source-derived product name is available through these pages.
- Rheumatic - Joint Care
- Uricum acidum, Aconitum nap.,Apis mel., Arnica, Arsenicum alb, Belladonna,Benzoicum acidum, Bryonia, Calc. carb., Chamomilla, Cinchona, Colchicum, Eupatorium perf., Gaultheriaprocumbens, Guaiacum, Iodium, Kali bic, Kalmia,Ledum, Pulsatilla, Rhus toxicodendron, Ruta,Sabina, Strychninum, Lappa, Phytolacca, Symphytum,
- Uric Acid
- Aconitum Napellus
- Apis Mellifera
- Arnica Montana
- Arsenic Trioxide
- Arsenic Cation (3+)
- Atropa Belladonna
- Benzoic Acid
- Bryonia Alba Root
- Oyster Shell Calcium Carbonate, Crude
- Matricaria Recutita
- Cinchona Officinalis Bark
- Colchicum Autumnale Bulb
- Eupatorium Perfoliatum Flowering Top
- Gaultheria Procumbens Top
- Guaiacum Officinale Resin
- Iodine
- Potassium Dichromate
- Dichromate Ion
- Kalmia Latifolia Leaf
- Ledum Palustre Twig
- Pulsatilla Vulgaris
- Toxicodendron Pubescens Leaf
- Ruta Graveolens Flowering Top
- Juniperus Sabina Leafy Twig
- Strychnine
- Arctium Lappa Root
- Phytolacca Americana Root
- Comfrey Root
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-2217 | 55714-2217-1, 55714-2217-2, 55714-2217-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e3670da3-03f6-4bed-4561-f244b9fa1df9 | cc3eac44-a75d-9768-b9c0-d81dca9ecefa | 2011-03-01 | Warnings | e3670da3-03f6-4bed-4561-f244b9fa1df9 cc3eac44-a75d-9768-b9c0-d81dca9ecefa |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
